ANTONIO
CANO SANCHEZ
CATEDRÁTICO/A DE UNIVERSIDAD
Hospital Universitario La Fe
Valencia, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario La Fe (15)
2023
-
Long-term effect of chemotherapy after ovarian decortication on the ovarian function in women surviving cancer
Journal of Assisted Reproduction and Genetics, Vol. 40, Núm. 12, pp. 2827-2834
2022
-
Cultural Beliefs, Perceptions, and Experiences on Female Genital Mutilation Among Women and Men: A Qualitative Analysis
Journal of Interpersonal Violence, Vol. 37, Núm. 17-18, pp. NP15504-NP15531
2021
-
Invasive ovarian seromucinous carcinoma developed on an endometrioma. The determining role of transvaginal ultrasound
Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 48, Núm. 3
-
The RANKL/RANK system in female reproductive organ tumors: A preclinical and clinical overview
Advances in Clinical and Experimental Medicine, Vol. 30, Núm. 10
-
The RANKL/RANK system in female reproductive organ tumors: A preclinical and clinical overview
Advances in clinical and experimental medicine : official organ Wroclaw Medical University
2017
-
The Impact of Hormone Therapy on Health
Menopause: A Comprehensive Approach (Springer International Publishing), pp. 225-247
-
The health challenges at menopause and midlife: Sustainability, ICT technology and patient empowerment
Menopause: A Comprehensive Approach (Springer International Publishing), pp. 333-342
2016
2014
-
Tuberculosis in a cohort of HIV-positive patients: Epidemiology, clinical practice and treatment outcomes
International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 6
2013
-
Transobturator suburethral tape in the treatment of stress urinary incontinence: Efficacy and quality of life after 5 year follow up
Maturitas, Vol. 74, Núm. 2, pp. 166-171
2009
-
No effect of Cimicifuga racemosa extract on serum interleukin-6 levels and prostacyclin production by human endothelial cells
European Journal of Obstetrics and Gynecology and Reproductive Biology
1999
-
Lipoprotein(a) levels and isoforms and fibrinolytic activity in postmenopause - Influence of Hormone Replacement Therapy
Thrombosis and Haemostasis, Vol. 81, Núm. 1, pp. 104-110
-
Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease. Influence of hormone replacement therapy
Thrombosis and Haemostasis, Vol. 81, Núm. 4, pp. 516-521
1998
-
Lipoprotein(a) [Lp(a)] levels and isoforms and fibrinolytic activity in postmenopause. Influence of hormone replacement therapy (HRT)
Fibrinolysis and Proteolysis, Vol. 12, Núm. SUPPL. 1, pp. 41
1995
-
The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status
American Journal of Obstetrics and Gynecology, Vol. 173, Núm. 6, pp. 1849-1854